Posted inBiotechnology
Neurological Targeting for Bone Regulation: Mechanisms & Therapies
Recent research has unveiled a transformative approach to understanding bone homeostasis, focusing on the interplay between the nervous system and…
Posted inBiotechnology
Innovative Smart Phenotyping Robot Revolutionizes Crop Monitoring to Enhance Food Security
In a groundbreaking stride towards revolutionizing agricultural research, a team of scientists from Nanjing Agricultural University has unveiled a state-of-the-art…
Posted inMedical Technology
Johnson & Johnson delivers 10-year Impella gains in severe heart attacks
After demonstrating last year that its miniaturized heart pumps could improve survival shortly after a serious heart attack, Johnson &…
Posted inBiotechnology
Amgen to build $600M R&D site, hire hundreds in California
Amgen is putting down $600 million to build a new R&D site in California, a move the Big Pharma says…
Posted inBiotechnology
Royalty bestows Zenas with $300M deal to push autoimmune asset across FDA finish line
Zenas BioPharma has secured up to $300 million from Royalty Pharma in return for royalties on sales of lead autoimmune…
Posted inMedical Technology
Medtronic scores insulin pump clearance in Type 2 diabetes, preps launch of Abbott Instinct CGM
Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed…
Posted inBiotechnology
Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods
Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multi-target drug discovery deal aiming to…
Posted inBiotechnology
12-Week Exercise Boosts Meteorin-like Levels in Seniors
A new study published in the European Geriatric Medicine journal has shed light on the profound effects of regular exercise…
Posted inBiotechnology
Scientists Identify Unique Brain Signaling Differentiating Parkinson’s Disease from Essential Tremor
In a groundbreaking study poised to redefine our understanding of movement disorders, scientists from Virginia Techâs Fralin Biomedical Research Institute…
Posted inBiotechnology
Novartis takes another shot at alpha-synuclein with $2.2B Arrowhead CNS deal
Novartis is taking another shot at alpha-synuclein as a target for treating Parkinson’s disease via a $200 million upfront licensing…